1. Home
  2. LOAN vs NSPR Comparison

LOAN vs NSPR Comparison

Compare LOAN & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • NSPR
  • Stock Information
  • Founded
  • LOAN 1989
  • NSPR 2005
  • Country
  • LOAN United States
  • NSPR Israel
  • Employees
  • LOAN N/A
  • NSPR N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • NSPR Medical/Dental Instruments
  • Sector
  • LOAN Real Estate
  • NSPR Health Care
  • Exchange
  • LOAN Nasdaq
  • NSPR Nasdaq
  • Market Cap
  • LOAN 65.8M
  • NSPR 63.0M
  • IPO Year
  • LOAN 1999
  • NSPR N/A
  • Fundamental
  • Price
  • LOAN $5.75
  • NSPR $3.19
  • Analyst Decision
  • LOAN
  • NSPR Strong Buy
  • Analyst Count
  • LOAN 0
  • NSPR 2
  • Target Price
  • LOAN N/A
  • NSPR $4.75
  • AVG Volume (30 Days)
  • LOAN 10.2K
  • NSPR 52.2K
  • Earning Date
  • LOAN 03-10-2025
  • NSPR 03-05-2025
  • Dividend Yield
  • LOAN 8.00%
  • NSPR N/A
  • EPS Growth
  • LOAN 6.53
  • NSPR N/A
  • EPS
  • LOAN 0.49
  • NSPR N/A
  • Revenue
  • LOAN $7,394,068.00
  • NSPR $6,821,000.00
  • Revenue This Year
  • LOAN N/A
  • NSPR $13.36
  • Revenue Next Year
  • LOAN N/A
  • NSPR $49.64
  • P/E Ratio
  • LOAN $11.73
  • NSPR N/A
  • Revenue Growth
  • LOAN 5.79
  • NSPR 24.70
  • 52 Week Low
  • LOAN $4.60
  • NSPR $1.81
  • 52 Week High
  • LOAN $5.90
  • NSPR $3.42
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 59.17
  • NSPR 63.51
  • Support Level
  • LOAN $5.55
  • NSPR $2.60
  • Resistance Level
  • LOAN $5.82
  • NSPR $3.11
  • Average True Range (ATR)
  • LOAN 0.09
  • NSPR 0.28
  • MACD
  • LOAN 0.00
  • NSPR 0.05
  • Stochastic Oscillator
  • LOAN 79.41
  • NSPR 87.15

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: